Literature DB >> 2429002

Interaction of bradykinin with substance P on vascular permeability and pain response.

M Shibata, T Ohkubo, H Takahashi, R Inoki.   

Abstract

Combination of bradykinin with substance P exerted synergistic effects on vascular permeability and pain response in mouse paw. Denervation of sciatic nerve reduced significantly bradykinin-induced vascular permeability, suggesting the involvement of sensory nerves. The bradykinin-induced vascular permeability was also reduced by intravenous injection of a substance P-antagonist. The results suggest that neuronal substance P takes part in the action of bradykinin on inflammation and pain sensation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2429002     DOI: 10.1254/jjp.41.427

Source DB:  PubMed          Journal:  Jpn J Pharmacol        ISSN: 0021-5198


  5 in total

1.  A bradykinin (BK)1 receptor antagonist blocks capsaicin-induced ear inflammation in mice.

Authors:  C R Mantione; R Rodriguez
Journal:  Br J Pharmacol       Date:  1990-03       Impact factor: 8.739

2.  Antinociceptive profile of the pseudopeptide B2 bradykinin receptor antagonist NPC 18688 in mice.

Authors:  C R Corrêa; D J Kyle; S Chakraverty; J B Calixto
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

3.  Evidence for participation of B1 and B2 kinin receptors in formalin-induced nociceptive response in the mouse.

Authors:  C R Corrêa; J B Calixto
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

4.  Substance-P-like levels in inflammatory exudates.

Authors:  M Tissot; P Pradelles; J P Giroud
Journal:  Inflammation       Date:  1988-02       Impact factor: 4.092

Review 5.  Animal Models of Inflammation for Screening of Anti-inflammatory Drugs: Implications for the Discovery and Development of Phytopharmaceuticals.

Authors:  Kalpesh R Patil; Umesh B Mahajan; Banappa S Unger; Sameer N Goyal; Sateesh Belemkar; Sanjay J Surana; Shreesh Ojha; Chandragouda R Patil
Journal:  Int J Mol Sci       Date:  2019-09-05       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.